SKIN
CANCER
CONNECT
August 2022
CASTLE BIOSCIENCES' PUBLICATIONS FEATURED IN SKIN'S 5-YEAR ANNIVERSARY EDITION
SKIN presented their Five-Year Anniversary Special Edition Issue of SKIN, The Journal of Cutaneous Medicine® . This special issue included the top 20 most read articles in the journal’s five-year history that had the largest impact on clinical care.
One of these articles featured the analysis demonstrating the clinical value of DecisionDx-Melanoma in risk of recurrence thin tumors. A second article featured the initial development and validation study of DiffDx-Melanoma for use in patients with an ambiguous or difficult-to-diagnose suspicious pigmented skin lesion.
CASE STUDY OF THE MONTH
Asymmetrical Pigmented Lesion with High Clinical Suspicion for Melanoma
A 27-year-old female patient was seen by a primary care physician who recommended follow-up with a dermatologist for assessment of a concerning melanocytic lesion.
RESEARCH & DEVELOPMENT
Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test
A new publication focused on DecisionDx-Melanoma was recently accepted in the Journal of the American Academy of Dermatology.